Stocks To Watch Today June 15: Vedanta Demerger, JSW Energy, ONGC, Power Grid Among Key Stocks In Focus
Indian markets’ June 15 watchlist includes Vedanta’s four demerged units—Vedanta Aluminium, Vedanta Oil & Gas, Vedanta Power and Vedanta Iron & Steel—starting trading on June 15. JSW Energy’s unit commissioned a 150 MW Tidong project; it also agreed to acquire Maruti Clean Coal & Power for Rs 1,410 crore. ONGC Petro Additions (OPaL) approved up to Rs 4,471 crore via NCDs.
How this was made
The 30-second read
Why it matters
The most tradable elements are first-day demerger trading (valuation reset), defined acquisition/contract values (JSW Energy, SEPC), and the US FDA OAI regulatory risk (Aurobindo). Other items (LOIs, delivery-center openings, patent ranking) are more narrative or pipeline-oriented without disclosed financial terms.
Market read
Traders may focus on demerger debut pricing, contract/acquisition value disclosures, and regulatory classification risk; however, the article provides limited deal terms and no market reaction data.
What to watch
For demergers and preferential allotments, dilution/issue price and index/ownership mechanics can dominate near-term price action; for FDA OAI, the specific products and remediation timeline are the key missing drivers.
Background
This is a multi-stock “stocks to watch” wrap for June 15, highlighting demerger debuts, project commissioning, fundraising/financing approvals, regulatory updates, and selected corporate actions across India.
Ticker impact
Dr Reddy’s launched Bosutinib Tablets 400 mg in the US as a generic version of Bosulif for CML treatment.
Positive bias as commercialization begins, though near-term magnitude depends on pricing/uptake not provided.
The article confirms launch and dosage but provides no sales expectations, launch timing details, or market share data.
Aditya Birla Capital’s board approved a capital raise of Rs 4,000 crore via preferential allotments led by Grasim Industries, IFC, and Suryaja Investments.
Mixed market reaction possible: capital strength positive, dilution/terms uncertain.
The article provides the raise size and participants, but not issue price, dilution math, or intended use.
Market effects
Energy/power names show a cluster of commissioning, transmission wins, and financing approvals; pharma has a regulatory-risk datapoint; financials show deposit-rate competition and capital raising.
India-focused catalysts (projects in Himachal Pradesh, Rajasthan, Andhra Pradesh, Jharkhand, Chhattisgarh) may support local sentiment in infrastructure/power supply chains.
US FDA classification and US generic launch create cross-border pharma risk/opportunity signals, but the article lacks broader macro linkages.
Counterpoint
Several items are commissioning/LOI/capital-raise approvals without disclosed economics; market reaction may be muted versus expectations until contract values, funding terms, and affected product details are clarified.
Key entities
- companyVedanta
Four demerged businesses are scheduled to start trading on 15 June.
- companyJSW Energy
Tidong hydro project commissioned; acquisition agreement for Maruti Clean Coal and Power announced.
- companyAurobindo
US FDA classified Eugia Pharma Unit-III inspection as “Official Action Indicated” (OAI).
- companyAditya Birla Capital
Board approved Rs 4,000 crore preferential allotment capital raise.
- companyHindustan Petroleum Corporation
Proposed final dividend of Rs 19.25/share for FY26 with August 14, 2026 record date.
